NeuroQ: A neurophobia screening tool assesses how roleplay challenges neurophobia
Journal of the Neurological Sciences. 2021-02-01; 421: 117320
DOI: 10.1016/j.jns.2021.117320
Lire sur PubMed
1. J Neurol Sci. 2021 Feb 15;421:117320. doi: 10.1016/j.jns.2021.117320. Epub
2021 Jan 20.
NeuroQ: A neurophobia screening tool assesses how roleplay challenges
neurophobia.
McGovern E(1), Louapre C(2), Cassereau J(3), Flamand-Roze C(4), Corsetti E(5),
Jegatheesan P(5), Bendetowicz D(2), Giron C(6), Dunoyer M(6), Villain N(2),
Renaud MC(7), Sauleau P(8), Michel L(9), Vérin M(10), Worbe Y(11), Falissard
B(12), Roze E(2).
Author information:
(1)AP-HP, Hôpital Pitié-Salpêtrière, Département de Neurologie, Paris, France;
Sorbonne Université, France; INSERM U1127, CNRS 7225, Institut du Cerveau,
Paris, France. Electronic address: .
(2)AP-HP, Hôpital Pitié-Salpêtrière, Département de Neurologie, Paris, France;
Sorbonne Université, France; INSERM U1127, CNRS 7225, Institut du Cerveau,
Paris, France.
(3)Université d’Angers, Faculté de Médecine, Angers, France; Hôpital
Universitaire d’Angers, Angers, France.
(4)Centre Hospitalier Sud-Francilien, Département de Neurologie, Corbeil,
France.
(5)AP-HP, Hôpital Pitié-Salpêtrière, Département de Neurologie, Paris, France.
(6)AP-HP, Hôpital Pitié-Salpêtrière, Département de Neurologie, Paris, France;
Sorbonne Université, France.
(7)Sorbonne Université, France.
(8)Hôpital Universitaire de Rennes, Département de Neurologie, Rennes, France;
Institut des Neurosciences Cliniques de Rennes, équipe EA4712, Rennes, France.
(9)Hôpital Universitaire de Rennes, Département de Neurologie, Rennes, France;
Université Rennes 1, Rennes, France.
(10)Hôpital Universitaire de Rennes, Département de Neurologie, Rennes, France;
Institut des Neurosciences Cliniques de Rennes, équipe EA4712, Rennes, France;
Université Rennes 1, Rennes, France.
(11)Sorbonne Université, France; INSERM U1127, CNRS 7225, Institut du Cerveau,
Paris, France; AP-HP, Hôpital Saint Antoine, Service de Neurophysiologie, Paris,
France.
(12)Centre de Recherche en Epidémiologie et Santé des Populations, Villejuif,
France; Université Paris-Saclay, Faculté de Médecine, Département de Santé
Publique, Villejuif, France.
Comment in
J Neurol Sci. 2021 Feb 15;421:117323. doi: 10.1016/j.jns.2021.117323.
BACKGROUND: Neurophobia is a chronic disease of medical students and junior
doctors. Early detection is needed to facilitate prevention and management as
this fear can negatively impact patient care.
METHODS: We conducted a two-part mono-centric study at the faculty of Medicine,
Sorbonne University, in Paris. Part one: a cross-sectional study to validate a
newly constructed neurophobia scale, NeuroQ. Part two: a prospective
longitudinal study to assess the impact of The Move on student neurophobia using
NeuroQ. A population-based sample of second-year medical students of the 2019
and 2020 class of the Faculty of Medicine of Sorbonne University were invited to
participate.
RESULTS: NeuroQ incorporates the main themes of the neurophobia definition and
demonstrates uni-dimensionality. Three hundred and ninety-five medical students
participated in the study (mean age was 20.0 years, SD: 2.1 years) assessing the
effect of The Move teaching on neurophobia. Two hundred and eighty-eight (72.9%)
students were female. After the Move teaching the mean NeuroQ score was
significantly lower compared to the baseline NeuroQ score (mean [SD] variation,
-1.1 [2.6], p